黴酚酸
參考文獻

1 2 3  Jasek, W (编).  62nd. Vienna: Österreichischer Apothekerverlag. 2007: 1484–95. ISBN 978-3-85200-181-4 （德语）.
1 2 3 4 5   (PDF). TGA eBusiness Services. Roche Products Pty Limited. 13 December 2012  [25 February 2014]. （原始内容存档于2020-07-08）.
↑  Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant.1996;10(1 Pt 2):77–84.
↑  . www.uptodate.com.   [2019-10-25]. （原始内容存档于2020-06-09）.
↑  . www.cth.org.tw.   [2017-05-13]. （原始内容存档于2022-03-30） （中文（臺灣））.
↑  . www.roche.com.tw.   [2017-05-13]. （原始内容存档于2017-05-16） （中文（臺灣））.
↑  Arns W, Breuer S, Choudhury S et al. Enteric-coated mycophenolate
sodium delivers bioequivalent MPA exposurecompared with mycophenolate mofetil. Clin Transplant 2005; 19(2): 199–206.
1 2 3  Silverman Kitchin, Jennifer E.; Pomeranz, Miriam Keltz; Pak, Grace; Washenik, Ken; Shupack, Jerome L. . Journal of the American Academy of Dermatology. 1997, 37 (3): 445–449. doi:10.1016/S0190-9622(97)70147-6.
1 2  . U.S. Food and Drug Administration.   [23 July 2014]. （原始内容存档于2017-07-22）.
1 2  Rossi S, editor. Australian Medicines Handbook（英语：） 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3[页码请求]
↑  editor, Mark Harber,. . 2014: 449  [2017-05-12]. ISBN 9781447155478. （原始内容存档于2018-12-21）.
↑  editor, Mark Harber. . 2014: 449  [2017-05-12]. ISBN 9781447155478. （原始内容存档于2018-12-21）.
1 2  Boehm, Ingrid; Bieber, Thomas. . Archives of Dermatology. 2001-02-01, 137 (2): 235–236  [2020-12-30]. ISSN 0003-987X. （原始内容存档于2020-03-28） （英语）.
1 2 3  Moore RA, Derry S. . Arthritis Research & Therapy. 2006, 8 (6): R182. PMC 1794528 . PMID 17163990. doi:10.1186/ar2093.
1 2  D'Cruz DP, Khamashta MA, Hughes GR. . Lancet. February 2007, 369 (9561): 587–96. CiteSeerX 10.1.1.1008.5428 . PMID 17307106. doi:10.1016/S0140-6736(07)60279-7.
↑  Walsh M, James M, Jayne D, Tonelli M, Manns BJ, Hemmelgarn BR. . Clinical Journal of the American Society of Nephrology. September 2007, 2 (5): 968–75. PMID 17702723. doi:10.2215/CJN.01200307.
↑  Knight SR, Russell NK, Barcena L, Morris PJ. . Transplantation. March 2009, 87 (6): 785–94. PMID 19300178. doi:10.1097/TP.0b013e3181952623.
↑  Knight SR, Russell NK, Barcena L, Morris PJ. . Transplantation. March 2009, 87 (6): 785–94. PMID 19300178. doi:10.1097/TP.0b013e3181952623.
↑  Remuzzi G, Lesti M, Gotti E,  et al. . Lancet. 2004, 364 (9433): 503–12. PMID 15302193. doi:10.1016/S0140-6736(04)16808-6.
↑  . reference.medscape.com.   [2017-05-12]. （原始内容存档于2021-04-30）.
↑  Publications, BNF. . www.bnf.org.   [2020-09-23]. （原始内容存档于2017-08-03）.
↑  . U.S. Food and Drug Administration. August 14, 2009  [2009-08-21]. （原始内容存档于2017-01-12）.
↑  . U.S. Food and Drug Administration. August 14, 2009  [2009-08-21]. （原始内容存档于2017-01-12）.
↑  . newsinferno.com. 2008-05-18  [2010-10-26]. （原始内容存档于2013-02-24）.
↑  . fda.gov. May 2008  [2010-10-26]. （原始内容存档于2017-01-12）.
↑  Budde K, Curtis J, Knoll G, Chan L, Neumayer HH, Seifu Y, et al.Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study.Am J Transplant. 2004;4(2):237–43.
↑  Salvadori M, Bertoni E, Budde K, Holzer H, Civati G, Lien B, et al. Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysis. Transplant Proc. 2010;42(4):1325–8.
↑  Pietruck F, Abbud-Filho M, Vathsala A, Massari PU, Po-HuangL, Nashan B. Conversion from mycophenolate mofetil to entericcoated mycophenolate sodium in stable maintenance renal transplant patients: pooled results from three international, multicenter studies. Transplant Proc. 2007;39(1):103–8.
↑  Sollinger HW, Sundberg AK, Leverson G, Voss BJ, Pirsch JD.Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustmentsand outcomes in kidney 2010;89(4):446–51
↑  Budde K, Dürr M, Liefeldt L, Neumayer HH, Glander P.Enteric-coated mycophenolate sodium. Expert Opin Drug Saf. 2010;9(6):981–94.
↑  Guido Filler& Ilan Buffo,Safety considerations with mycophenolate sodium Expert Opin. Drug Saf. (2007) 6(4)
↑  Drugs.com: Mycophenolic acid 副作用
↑  . Lippincott Williams & Wilkins. 2014: 625. ISBN 978-1-4511-9177-6.
↑  Parnham, edited by F.P. Nijkamp, M.J.  2nd rev. and extended. Basel: Birkhèauser Verlag. 2005: 453. ISBN 978-3764358044.
↑  Fu, Rong; Ceballos-Picot, Irene; Torres, Rosa J.; Larovere, Laura E.; Yamada, Yasukazu; Nguyen, Khue V.; Hegde, Madhuri; Visser, Jasper E.; Schretlen, David J.; Nyhan, William L.; Puig, Juan G.; O’Neill, Patrick J.; Jinnah, H. A. . Brain. May 2014, 137 (5): 1282–1303. PMC 3999711 . PMID 23975452. doi:10.1093/brain/awt202.
↑  Anderson, HA; Bracewell, JM; Fraser, AR; Jones, D; Robertson, GW; Russell, JD. . Transactions of the British Mycological Society. December 1988, 91 (4): 649–651. doi:10.1016/S0007-1536(88)80040-8.
↑  Fulton B, Markham A. "Mycophenolate mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation." Drugs. 1996, 51(2):278-98.
↑  Ransom JT. . Therapeutic Drug Monitoring. December 1995, 17 (6): 681–4. PMID 8588241. doi:10.1097/00007691-199512000-00023.
↑  Dooley, MA; Jayne, D; Ginzler, EM; Isenberg, D; Olsen, NJ; Wofsy, D; Eitner, F; Appel, GB; Contreras, G; Lisk, L; Solomons, N; ALMS Group. . New England Journal of Medicine. 17 November 2011, 365 (20): 1886–95. doi:10.1056/NEJMoa1014460.
↑  W. Zhang, C. Ding, S. Enteric-coated mycophenolate sodium: an update Int J Clin Pract, April 2014, 68 (Suppl. 181), 1–3
↑   (PDF).   [2017-05-12]. （原始内容 (PDF)存档于2007-03-15）.
↑  Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC. . Archives of Dermatology. June 2003, 139 (6): 739–42. PMID 12810504. doi:10.1001/archderm.139.6.739.
↑  Diamond MS, Zachariah M, Harris E. . Virology. 2002, 304 (2): 211–21. PMID 12504563. doi:10.1006/viro.2002.1685.
↑  Takhampunya R, Ubol S, Houng HS, Cameron CE, Padmanabhan R. . The Journal of General Virology. July 2006, 87 (Pt 7): 1947–52. PMID 16760396. doi:10.1099/vir.0.81655-0.
↑  Zhang, Lixin; Demain, Arnold L. . Totowa, N.J.: Humana Press. 2005: 14  [2019-10-30]. ISBN 9781592599769. （原始内容存档于2020-08-01）.
↑  Regueira, T. B.; Kildegaard, K. R.; Hansen, B. G.; Mortensen, U. H.; Hertweck, C.; Nielsen, J. . Applied and Environmental Microbiology. 2011, 77 (9): 3035–3043. PMC 3126426 . PMID 21398490. doi:10.1128/AEM.03015-10.
↑  Bentley, Ronald. . Chemical Reviews. 2000, 100 (10): 3801–3826. PMID 11749328. doi:10.1021/cr990097b.
↑  Watts, Geoff. . The Lancet. 2014, 383 (9925): 1290. doi:10.1016/S0140-6736(14)60635-8.
↑  Allison, Anthony C. . Immunopharmacology. 2000, 47 (2–3): 63–83. PMID 10878284. doi:10.1016/S0162-3109(00)00186-7.
↑  Allison, AC; Kowalski, WJ; Muller, CD; Eugui, EM. . Annals of the New York Academy of Sciences. 1993, 696 (1): 63–87. PMID 7906496. doi:10.1111/j.1749-6632.1993.tb17143.x.
↑  Nelson, PH; Eugui, E; Wang, CC; Allison, AC. . Journal of Medicinal Chemistry. 1990, 33 (2): 833–838. PMID 1967654. doi:10.1021/jm00164a057.
↑  Eugui, Elsie M.; Allison, Anthony C. . Annals of the New York Academy of Sciences. 1993, 685 (1): 309–329. PMID 8363235. doi:10.1111/j.1749-6632.1993.tb35881.x.
↑  Allison, AC; Eugui, EM. . Clinical Transplantation. 1996, 10 (1 Pt 2): 77–84. PMID 8680053.
↑  Allison, AC; Eugui, EM. . Springer Seminars in Immunopathology. 1993, 14 (4): 353–80. PMID 8322167. doi:10.1007/bf00192309.
↑  Allison, AC; Eugui, EM. . Immunological Reviews. 1993, 136 (1): 5–28. PMID 7907572. doi:10.1111/j.1600-065x.1993.tb00652.x.
↑  Bechstein, WO; Suzuki, Y; Kawamura, T; Jaffee, B; Allison, A; Hullett, DA; Sollinger, HW. . Transplant International. 1992, 5 (Suppl 1): S482–3. PMID 14621853. doi:10.1111/tri.1992.5.s1.482.
↑  Kawamura, T; Hullett, DA; Suzuki, Y; Bechstein, WO; Allison, AM; Sollinger, HW. . Transplantation. 1993, 55 (4): 691–4; discussion 694–5. PMID 8475537. doi:10.1097/00007890-199304000-00001.
↑  Taylor, DO; Ensley, RD; Olsen, SL; Dunn, D; Renlund, DG. . The Journal of Heart and Lung Transplantation. 1994, 13 (4): 571–82. PMID 7947873.
↑  Donlon, Diane M. . Stanford University. 15 June 1995  [23 July 2014]. （原始内容存档于2020-09-25）.
↑  . Roche.com. F. Hoffmann-La Roche Ltd.   [23 July 2014]. （原始内容存档于2014-07-26）.
↑  . Transpl Int. 2015. PMID 25758949. doi:10.1111/tri.12554.